This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smith, S. B. Articles by German, M. S. Search for Related Content PubMed PubMed Citation Articles by Smith, S. B. Articles by German, M. S. Pubmed/NCBI databases Substance via MeSH

Neurogenin3 Activates the Islet Differentiation Program while Repressing Its Own Expression

Diabetes Center (S.B.S., H.W., M.S.G.), Hormone Research Institute and Department of Medicine (M.S.G.), University of California San Francisco, San Francisco, California 94143-0534

Address all correspondence and requests for reprints to: Michael S. German, Hormone Research Institute, University of California San Francisco, 513 Parnassus Avenue, San Francisco, California 94143-0534. E-mail: mgerman{at}biochem.ucsf.edu.

Expression of the proendocrine factor Neurogenin3 determines which progenitor cells in the developing pancreas will differentiate into the endocrine cells of the islets of Langerhans. To better understand how Neurogenin3 directs endocrine differentiation, we examined the mechanisms by which Neurogenin3 regulates the promoters of three transcription factor genes expressed in endocrine precursor cells: the nkx2.2 gene, the PAX4 gene, and the NEUROG3 gene, the human gene encoding Neurogenin3 itself. The function of all three promoters depends on at least one critical E box, a common DNA sequence that forms a binding site for basic helix-loop-helix proteins like Neurogenin3. Neurogenin3 bound to and effectively activated transcription through the nkx2.2 and PAX4 E boxes. In contrast, Neurogenin3 strongly repressed the NEUROG3 promoter, although a proximal E box was required for activity in the absence of Neurogenin3, suggesting that a ubiquitous transcriptional activator may bind to this site, and that Neurogenin3 could act as a competitive inhibitor of this activator. This hypothesis was supported by the lack of evidence for significant intrinsic transcriptional repression capacity in the Neurogenin3 protein, and by the ability of isolated DNA-binding basic helix-loop-helix domains to repress the NEUROG3 promoter. Neurogenin3 produced additional repression, however, when the protein included an intact transcriptional activation domain, suggesting that it may also induce the expression of a downstream transcriptional repressor. In summary, while Neurogenin3 orchestrates islet cell differentiation by activating islet cell transcription factor genes, it simultaneously represses its own promoter.

This article has been cited by other articles:

				J. M. Oliver-Krasinski and D. A. Stoffers On the origin of the {beta} cell Genes & Dev., August 1, 2008; 22(15): 1998 - 2021. [Abstract] [Full Text] [PDF]

				P. White, C. Lee May, R. N. Lamounier, J. E. Brestelli, and K. H. Kaestner Defining Pancreatic Endocrine Precursors and Their Descendants Diabetes, March 1, 2008; 57(3): 654 - 668. [Abstract] [Full Text] [PDF]

				T. Brun and B. R Gauthier A focus on the role of Pax4 in mature pancreatic islet {beta}-cell expansion and survival in health and disease J. Mol. Endocrinol., February 1, 2008; 40(2): 37 - 45. [Abstract] [Full Text] [PDF]

				C. S. Lee, D. D. De Leon, K. H. Kaestner, and D. A. Stoffers Regeneration of Pancreatic Islets After Partial Pancreatectomy in Mice Does Not Involve the Reactivation of Neurogenin-3 Diabetes, February 1, 2006; 55(2): 269 - 272. [Abstract] [Full Text] [PDF]

				M. E. Wilson, K. Y. Yang, A. Kalousova, J. Lau, Y. Kosaka, F. C. Lynn, J. Wang, C. Mrejen, V. Episkopou, H. C. Clevers, et al. The HMG Box Transcription Factor Sox4 Contributes to the Development of the Endocrine Pancreas Diabetes, December 1, 2005; 54(12): 3402 - 3409. [Abstract] [Full Text] [PDF]

				T. Iype, D. G. Taylor, S. M. Ziesmann, J. C. Garmey, H. Watada, and R. G. Mirmira The Transcriptional Repressor Nkx6.1 Also Functions as a Deoxyribonucleic Acid Context-Dependent Transcriptional Activator during Pancreatic {beta}-Cell Differentiation: Evidence for Feedback Activation of the nkx6.1 Gene by Nkx6.1 Mol. Endocrinol., June 1, 2004; 18(6): 1363 - 1375. [Abstract] [Full Text] [PDF]

				S. E. Schonhoff, M. Giel-Moloney, and A. B. Leiter Minireview: Development and Differentiation of Gut Endocrine Cells Endocrinology, June 1, 2004; 145(6): 2639 - 2644. [Abstract] [Full Text] [PDF]